Exploring the association between statins use or HMG-CoA reductase inhibition and migraine: a systematic review and meta-analysis
Abstract Background Statins or 3‑hydroxy‑3‑methyl‑glutarylcoenzyme A (HMG‑CoA) reductase inhibitors are medications that act by reducing the cholesterol content of liver cells Moreover, statins have been found to improve endothelial function and reduce vascular wall inflammation. A growing body of r...
Saved in:
Main Authors: | Hamdy A. Makhlouf, Amr K. Hassan, Nereen A. Almosilhy, Ahmed S.A. Osman, Shrouk Ramadan, Moaz Elsayed Abouelmagd |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-02-01
|
Series: | The Journal of Headache and Pain |
Subjects: | |
Online Access: | https://doi.org/10.1186/s10194-025-01957-w |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Frameshift variation in the HMG-CoA reductase gene and unresponsiveness to cholesterol-lowering drugs in type 2 diabetes mellitus patients
by: Esmat Khaleqsefat, et al.
Published: (2025-01-01) -
Phenolics from grapefruit peels inhibit HMG-CoA reductase and angiotensin-I converting enzyme and show antioxidative properties in endothelial EA.Hy 926 cells
by: Ayokunle O. Ademosun, et al.
Published: (2015-06-01) -
Epidemiology of clinically significant migraine in Israel: a retrospective database study
by: A. Shifrin, et al.
Published: (2025-02-01) -
Effect of lemongrass water extract supplementation on atherogenic index and antioxidant status in rats
by: Somparn Nuntiya, et al.
Published: (2018-06-01) -
The epidemiology and unmet need of migraine in five european countries: results from the national health and wellness survey
by: Gianluca Coppola, et al.
Published: (2025-01-01)